Why the study?
Does pitavastatin improve lipid profiles and promote coronary plaque regression in patients with primary hypercholesterolemia or combined dyslipidemia?
Does pitavastatin improve lipid profiles and promote coronary plaque regression in patients with primary hypercholesterolemia or combined dyslipidemia?
Pitavastatin is an effective statin for reducing LDL-C, elevating HDL-C, and promoting coronary plaque regression in patients with primary hypercholesterolemia or combined dyslipidemia.
No takes yet. Share an insight, caveat, or question.
May support pitavastatin for LDL-C reduction and plaque regression in dyslipidemia; leaves open confirmation by prospective RCTs.
Junichi Sasaki (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: